Medical devices giant Abbott has also helped the effort against the coronaviruspandemic with a fast test kit, which could be an important development in the US where there is a national shortage of tests. In January, J&J was one of the first companies to announce it had started work on a vaccine after Chinese scientists published the genetic code of the SARS-CoV-2 virus that causes the disease. Now the company’s Janssen unit said it has identified a suitable vaccine candidate and has expanded an existing partnership with the US government agency the Biomedical Advanced Research and Development Authority (BARDA). https://gr-cis.com/2020/04/01/jj-and-us-government-invest-1-billion-in-covid-19-vaccine/ #coronavirus #Regulatoryaffairs #Regulatorychange #US #J&J